Ibrahim Mortada

Disclosure(s): No financial relationships to disclose

Presentation(s):

• Comparative Outcomes Of Tirzepatide To Dpp4 Inhibitors In Patients With Heart Failure And Type 2 Diabetes

  Monday, March 9, 2026
  10:03 AM - 10:09 AM EST

• Empagliflozin Vs Dapagliflozin In Patients With Heart Failure With Mid-range Ejection Fraction

  Monday, March 9, 2026
  10:15 AM - 10:21 AM EST

• Performance Of Risk Scores In Predicting Right Ventricular Failure After Lvad Implantation

  Monday, March 9, 2026
  10:33 AM - 10:39 AM EST

• Additive Cardiorenal Benefits Of Finerenone And Sglt2 Inhibitor Combination Therapy In Diabetic Ckd: A Propensity-matched Real-world Study

  Monday, March 9, 2026
  2:12 PM - 2:18 PM EST